IOBT – io biotech, inc. (US:NASDAQ)
Stock Stats
News
IO Biotech, Inc. (NASDAQ: IOBT) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $12.00 price target on the stock.
IO Biotech Reports Third Quarter 2024 Financial Results and Provides Business Highlights [Yahoo! Finance]
IO Biotech Reports Third Quarter 2024 Financial Results and Provides Business Highlights
IO Biotech Announces Participation in Upcoming Investor Conferences
IO Biotech Reports its Off-the-Shelf Therapeutic Cancer Vaccine, IO102-IO103, in Combination with KEYTRUDA® Demonstrates Promising Activity and Durability in First-line Treatment of Patients with Metastatic Lung Cancer in Phase 2 IOB-022 Study
Form SC 13G/A IO Biotech, Inc. Filed by: Stonepine Capital Management, LLC
Form 10-Q IO Biotech, Inc. For: Sep 30
Form 8-K IO Biotech, Inc. For: Nov 12
Form SC 13D/A IO Biotech, Inc. Filed by: Novo Holdings A/S
Form 144 IO Biotech, Inc. Filed by: Novo Holdings A/S
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.